About
Co-founder and Senior Advisor at Medicxi who previously spent 13 years as a Partner at Index Ventures, where he originated its first asset-centric investment and led Medicxi's investment in Impact Biomedicines. Earlier he was Research Director and CTO at Cambridge Antibody Technology, contributing to antibodies now marketed as Humira and Benlysta.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Experience
- Medicxi VenturesGeneral Partnercurrent2016 — presentLondon Area, United Kingdom
- Index VenturesVenture Partner2010 — 2016
- Index VenturesVenture Advisor2003 — 2010
- PanGenetics BVCEO2005 — 2010
- Ash Biotech ConsultingOwner2003 — 2010
- Cambridge Antibody TechnologyChief Technology Officer1990 — 2003
Skills & more
Vaccines11Technology Transfer36Drug Development63Lifesciences19Biotechnology51Start-ups21Venture Capital29R&D13Biochemistry9Drug Discovery16Antibodies9Molecular Biology6
+12 more
Clinical DevelopmentImmunologyBiopharmaceuticalsGenomicsCellBioinformaticsMedical DevicesPatentsProtein ChemistryCommercializationCorporate DevelopmentLicensingFrom Kevin's professional profile.
Investments
Led
Impact Biomedicines
Board seats
Crescendo BiologicsLevicept
Investor
PanGenetics
Per the firm's website.
Colleagues at Medicxi
Frequently asked questions
- Who is Kevin Johnson?
- Co-founder and Senior Advisor at Medicxi who previously spent 13 years as a Partner at Index Ventures, where he originated its first asset-centric investment and led Medicxi's investment in Impact Biomedicines. Earlier he was Research Director and CTO at Cambridge Antibody Technology, contributing to antibodies now marketed as Humira and Benlysta.
- Where does Kevin Johnson work?
- Kevin Johnson is Co-founder & Senior Advisor at Medicxi.
- What does Kevin Johnson invest in?
- Kevin Johnson invests in Biotech, Healthtech, Medical Devices.
- What boards does Kevin Johnson sit on?
- Kevin Johnson holds tracked board seats at Crescendo Biologics, Levicept.
- What companies has Kevin Johnson invested in?
- Investments tracked here include Impact Biomedicines, PanGenetics.
- Where did Kevin Johnson go to school?
- Kevin Johnson studied at University of Cambridge (PhD, Molecular Parasitology); The University of Edinburgh (BSc (hons), Molecular Biology); University of Melbourne (Post Doc, Vaccines).
- Does Kevin Johnson lead rounds?
- Yes — Kevin Johnson has led 1 tracked investment.
Same school
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 887 more
Also attended The University of Edinburgh208
Sofia DolfeInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiPatrick NorrisGeneral Partner at Notion CapitalSarah MandersonLegal Director at Hoxton VenturesXan WoodInvestor at Canvas VenturesEmily PawlakVice President at Volition Capital
.jpg)
+ 202 more
Also attended University of Melbourne231
Cameron AdamsCo-founder & Chief Product Officer of CanvaEsther GilmoreGlobal Head of the Client Team at Generation Investment ManagementMark MillsClient Team Member at Generation Investment ManagementPaulInvestor at Square Peg CapitalClarissa KartikaAssociate, Investment at Vertex Ventures Sea Management Pte. Ltd.Dan KrasnosteinPartner at Square Peg Capital
:format(webp)/f/174198/3860x2650/d857c55b6f/steel-blue-clarissa.png)
+ 225 more
Shared employers
Also worked at Index Ventures126
Danny RimerPartner at Index VenturesAdrianna MaInvestor at Index VenturesAli Fisher SweetInvestor at Index VenturesAna AndreescuInvestor at Index VenturesAndré DuboisInvestor at Index VenturesAvron MarcusInvestor at Index Ventures
+ 120 more
